Chemistree Acquires Ownership Stake in The Physician's Choic VANCOUVER, April 29, 2019 /PRNewswire/ - Chemistree Technology Inc. (CSE:CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the Company has entered into a funding agreement with The Physician's Choice CBD LLC of Phoenix, Arizona.
The Physician's Choice CBD ("PCCBD") is dedicated to research, development, and utilization of the highest quality of hemp-derived cannabidiol (CBD) combined with well-studied and effective supplements specific to help regulate and support various symptoms. The integration of extensive physician clinical experience combined with exhaustive expertise in the cannabis industry has led to the creation of The Physician's Choice CBD.
Established in 2018, PCCBD has already developed a suite of nine full spectrum CBD from Hemp products ranging from pain/inflammation management to sleep and wellness supplements. In it's first quarter of sales ended January 2019, the company booked approximately $150,000 in sales. The products are available for purchase at www.pccbd.com and distributed through healthcare providers across the U.S. The Physicians Choice CBD offers complete wholesale programs as well as a referral program compensating healthcare providers on purchases from codes provided to their patients.
https://finance.yahoo.com/news/chemistree-acquires-ownership-stake-physicians-113000356.html